Posted by Investeye > 2018-08-27 20:41 | Report Abuse

Q2Q is slightly better (but lower compared previous Q). Today share price up 7% already, so further up is just a ?.. Overall it is still reasonable.

Posted by Stephenloo > 2018-09-07 22:02 | Report Abuse

no more show?

Posted by Investeye > 2018-09-08 09:41 | Report Abuse

Time to collect again at this attractive price...

Posted by chandra54 > 2018-09-13 14:57 |

Post removed.Why?

Posted by jason007 > 2018-09-13 16:09 | Report Abuse

sell !

Posted by Romyzam > 2018-09-13 17:40 | Report Abuse

On board. Need to go back 1.27 for uptrend. Cheap at current price. Today forced selling that's y can get low price. Let's see tomorrow.

Posted by chandra54 > 2018-09-18 13:03 | Report Abuse

yeah romyzam, will go hopless yet again. forget to smell 1.27. this prise is history

Posted by chandra54 > 2018-09-18 13:04 |

Post removed.Why?

Posted by jordanmaggie61 > 2018-09-18 15:26 | Report Abuse

Good show ! Very strong... will move tomorrow and profit incoming

Posted by Gavin Chua > 2018-09-18 22:57 | Report Abuse

may i know CCMBIO's competitors ?

Posted by jibbie > 2018-09-19 16:38 | Report Abuse

pharmaniaga, yspsah, hovid

Posted by Romyzam > 2018-09-19 18:28 | Report Abuse

Nice recovery today. More to come tomorrow. Really hope back to 1.27 and above...

Posted by chandra54 > 2018-09-25 10:15 |

Post removed.Why?

Posted by Romyzam > 2018-09-25 11:58 | Report Abuse

Cool Chandra. Now accumulation time. I bought total 100k shares from 1.15 to 1.19. If break 1.14 again then cut lo

Posted by Romyzam > 2018-09-26 13:16 | Report Abuse

Nicely back to 1.26 today.

Posted by Romyzam > 2018-10-02 19:14 | Report Abuse

Sold back all 1.23 to 1.26. Good luck those still holding. Good counter but too slow. Thanks ccmdbio for the quick bucks.

Posted by Investeye > 2018-10-03 20:24 | Report Abuse

Take opportunity to accumulate more based on EPF kept accumulating recently. In fact after holding some lots for 1.5 yrs, it is still gaining at this price ( due to bonus 4:3 issuing 15 maths ago)

Posted by 04TSH > 2018-10-04 16:09 | Report Abuse

Interesting feedbacks and advices guys

Posted by Romyzam > 2018-10-11 12:05 | Report Abuse

Buy back 1.12. Cheap sale.

Posted by Stephenloo > 2018-10-22 19:29 | Report Abuse

Declared 1.5 cent dividen

Posted by YKLIEW > 2018-11-02 21:45 | Report Abuse

Bought 1-28 down 20 sen but get 1.5 sen dividend. Terrible investment yo

Posted by moneytrail > 2018-11-03 15:46 | Report Abuse

Collect for long term, consistent profit this 2 years. Factory expansion to bear fruit 2020. Niche product and stem cells product, hope to give higher margin to offset margin erosion from competitive generic drugs.

Posted by jinghee > 2018-11-08 20:55 | Report Abuse

Will the government budget benefit this company?

Posted by Hafid > 2018-11-15 16:16 | Report Abuse

people are selling

Posted by kmwong8711 > 2018-11-16 10:55 | Report Abuse

Today quarter results out??

Posted by necro > 2018-11-22 09:55 | Report Abuse

I must said recent acquisition & ventures were uninteresting to investor, too many drug & substances in pipeline. Investor dont understand of what is the drug is going to do with Malaysia market.

Asean is not like Singapore, Japan or Korea where the country spend 7% of GDP for healthcare budget, Malaysia for example is only use of 3% GDP for healthcare budget.

Malaysia healthcare priority budgeting only for "3 serangkai" diseases which diabetes, high blood pressure & heart diseases. Disease like autoimmune, chronic kidney disease(ckd), obstetric &, gynaecology using advance medication were too expensive for government to used.

Hopefully CEO does not to eager to pursuing pipeline quantity but focus more on quality, he must realise that that CCMDBIO is conglomerates not science lab where he can test new drug or substances onto Malaysian people.

Posted by moneytrail > 2018-11-28 22:56 | Report Abuse

Good resukts

Posted by Tete7893 > 2018-12-26 17:45 | Report Abuse

Luckily run early.

Posted by Yi Heng > 2019-01-22 19:22 | Report Abuse

0.94 all in

Posted by Nicholasming91 > 2019-02-18 19:01 | Report Abuse

Can buy wow

Posted by Yi Heng > 2019-02-18 19:23 | Report Abuse

yes, dividend 4 sen if approved

Posted by Investeye > 2019-02-18 22:08 | Report Abuse

CCM Duopharma Biotech Bhd’s fourth quarter net profit rose 18.45% to RM14.37 million from RM12.13 million a year ago, due to higher revenue and changes in accounting policies arising from adoption of the Malaysian Financial Reporting Standards 9 (MFRS 9).
Earnings per share for the quarter ended Dec 31, 2018 rose to 2.17 sen from 1.86 sen.
Quarterly revenue was up 3.01% to RM115.63 million, from RM112.25 million previously, the group said in a filing with Bursa Malaysia.
CCM Duopharma has declared a final dividend of four sen, bringing total payout for FY18 to 5.5 sen, as against 3.64 sen in FY17.
The group has also proposed that the dividend reinvestment plan would apply to the final dividend.
For FY18 as a whole, CCM Duopharma’s net profit increased 12.19% to RM47.64 million or 7.26 sen per share from RM42.46 million or 6.52 sen per share last year, while revenue grew 6.57% to RM498.72 million from RM467.99 million.
On prospects, the group said it sees opportunities from the increase in allocation for health services to RM29 billion in Budget 2019 including RM10.8 billion to restore clinics and hospitals as well to buy medicine and medical equipment.
“The group will also continue its foray into the specialty products as one of its strategies moving forward to create a pool of niche products,” said CCM Duopharma, adding that it has recently received registration approval for Erysaa, an erythropoeitin product.
Barring any unforeseen circumstances, the group expects to achieve satisfactory results in FY19.

Posted by shpg22 > 2019-02-18 22:49 | Report Abuse

Liquidity has deteriorated quite rapidly, still able to give 4cents dividend. Good management

Posted by chshzhd > 2019-02-19 10:41 | Report Abuse

good dividend

Posted by chshzhd > 2019-02-19 10:45 | Report Abuse

but profit improved is due to adoption of MFRS.

Posted by Yi Heng > 2019-02-19 12:30 | Report Abuse

wait it correction and buy again :)

Posted by tac2255 > 2019-02-19 16:14 | Report Abuse

finally it gap up

Posted by LOLANTO > 2019-02-19 20:20 | Report Abuse

what correction.... it's just the very beginning of the rally. buy before it is too late!

Posted by James Ng > 2019-02-20 11:52 | Report Abuse

https://klse.i3investor.com/blogs/general/194224.jsp
[转贴] [CCM DUOPHARMA BIOTECH BHD：进军特种产品，作为其创建一系列利基产品的战略之一，它最近获得了红细胞生成素产品Erysaa的注册批准] - James的股票投资James Share Investing

Posted by Investeye > 2019-02-20 17:07 | Report Abuse

SHAH ALAM (Feb 20): CCM Duopharma Biotech Bhd (CCMD) is hopeful of getting its RM10 million goods and services tax (GST) refund from the government within this year.

"We are in the process [of getting the refund]. There are still questions that need to be addressed with the Ministry of Finance (MoF), but we are quite happy with the announcement about the refund. Hopefully, it will be refunded within this financial year," CCMD group managing director Leonard Ariff Abdul Shatar told the press at its extraordinary general meeting (EGM) here.

Last August, Leonard Ariff told The Edge Financial Daily that the government still owed CCMD about RM10 million in GST refunds.

Posted by factorrumour > 2019-02-22 22:38 | Report Abuse

"A final dividend of 4.0sen/share was proposed (FY18: 5.5sen/share vs. FY17: 3.6sen/share). This translates to a dividend payout ratio of 68%, which is much higher than FY17 payout ratio of 55%."

how did this guy get FY17: 3.6sen/share?

Posted by factorrumour > 2019-02-25 22:51 | Report Abuse

congrats to all shareholders, a new beginning awaits you all

duopharma biotech!

Posted by cmshyong > 2019-02-26 19:35 | Report Abuse

when is the ex date for 4 sen dividen?

Posted by catchcon > 2019-03-11 05:13 | Report Abuse

factorrumour congrats to all shareholders, a new beginning awaits you all

duopharma biotech!

It's good brother, better things to come.

Posted by chshzhd > 2019-03-12 11:43 | Report Abuse

@factorrumour div for fy17 was 3.6sen bcos the adjustment of bonus issue at june last year

Posted by chshzhd > 2019-03-12 11:45 | Report Abuse

..so div 5.5sen for fy18 actually is an improvement of 55% !

Posted by chshzhd > 2019-03-12 11:46 | Report Abuse

@cmshyong the ex date for 4 sen will be around june this year.

Posted by Chengkai Kok > 2019-03-12 13:26 | Report Abuse

目标价：1.52令吉
最新进展：

联合药业（DPHARMA，7148，主板保健股）持续预见大马公共和私人保健领域需求强劲，归功政府增加卫生部拨款。

联合药业去年的销售量仍是大马领先业者；而以销售值来看，从第三名攀升至第二名。

该公司近期取得相关机构批准，出售红血球生成素（EPO）生物仿制药，同时肿瘤设备料于今年第三季推介。

在大马，肿瘤科产品市值高达4亿令吉，所以该利基产品有巨大的机会。

目前本地还未有肿瘤科的设备，该公司计划推出2至3种主要产品来夺得25%市占率（1亿令吉）。

行家建议：

我们预计，联合药业可赢得新的EPO合约、及更新胰岛素合约，并保住市场领导地位。

我国的EPO市场市值达5000万令吉至6000万令吉间，相信该公司有能力与其他供应商竞争，争夺政府大约介于1000万令吉至1500万令吉的合约。

针对今年到期的胰岛素合约，相信该公司可凭借更便宜的价格，延长现有合约2年；若失败，将冲击下财年盈利预测7%。

Posted by keyin > 2019-03-16 12:16 | Report Abuse

Why no movement,boring

Posted by Manekineko > 2019-03-18 12:32 | Report Abuse

Hahaha, healthcare counter is like that la... Slow but steady...